Related Funds
Fund Name | Location |
200M | Lisboa, Portugal, Setúbal |
Arkoma Venture Partners | Dallas, Texas, United States |
Asuka Asset Management | Japan, Tokyo |
CXT Investments | - |
Cypress Hills Partners | British Columbia, Canada, Vancouver |
DF International Partners | - |
Elbit Imaging Ltd. | Israel, Tel Aviv, Tel Aviv District |
Funding Circle | England, London, United Kingdom |
Hantan Capital | China, Shanghai, Xuhui |
JCB Investments | Indiana, Seymour, United States |
June Fund | Berlin, Berlin, Germany |
Krause und Kollegen | - |
Light Silver Capital | Beijing, China, Haidian |
LSI Logic | California, Milpitas, United States |
Octagon Investments | - |
S7V | - |
T Fund | California, San Mateo, United States |
Tremendous View Capital | Brooklyn, New York, United States |
YMG Capital Management | Canada, Ontario, Toronto |
Yule Gongchang | Beijing, Beijing, China |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Relay Therapeutics | $400M | 20 Dec 2018 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Relay Therapeutics | $400M | 20 Dec 2018 | Cambridge, Massachusetts, United States |